Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAPS-2 trial
2016-003406-14Phase 3Terminated
- Sponsor
- University Hospital of North Midlands
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metoclopramide in stroke and aspiration pneumonia (4 arms), sponsored by University Hospital of North Midlands. Primary endpoint: Mortality up to the end of the study. Started May 2018; status: terminated.
02
Drugs
metoclopramide
03
Conditions
strokeaspiration pneumonia
Beyond the preview
Go deeper on 2016-003406-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003406-14.